EYPT
Price
$9.59
Change
-$0.05 (-0.52%)
Updated
Jun 30, 02:13 PM (EDT)
Capitalization
663.35M
30 days until earnings call
LYRA
Price
$8.51
Change
-$0.60 (-6.59%)
Updated
Jun 30, 12:06 PM (EDT)
Capitalization
12.07M
43 days until earnings call
Interact to see
Advertisement

EYPT vs LYRA

Header iconEYPT vs LYRA Comparison
Open Charts EYPT vs LYRABanner chart's image
EyePoint Pharmaceuticals
Price$9.59
Change-$0.05 (-0.52%)
Volume$200
Capitalization663.35M
Lyra Therapeutics
Price$8.51
Change-$0.60 (-6.59%)
Volume$100
Capitalization12.07M
EYPT vs LYRA Comparison Chart in %
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. LYRA commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Hold and LYRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (EYPT: $9.64 vs. LYRA: $9.11)
Brand notoriety: EYPT and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 220% vs. LYRA: 81%
Market capitalization -- EYPT: $663.35M vs. LYRA: $12.07M
EYPT [@Biotechnology] is valued at $663.35M. LYRA’s [@Biotechnology] market capitalization is $12.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileLYRA’s FA Score has 0 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • LYRA’s FA Score: 0 green, 5 red.
According to our system of comparison, EYPT is a better buy in the long-term than LYRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 6 TA indicator(s) are bullish while LYRA’s TA Score has 3 bullish TA indicator(s).

  • EYPT’s TA Score: 6 bullish, 4 bearish.
  • LYRA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than LYRA.

Price Growth

EYPT (@Biotechnology) experienced а +14.49% price change this week, while LYRA (@Biotechnology) price change was -12.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.66%. For the same industry, the average monthly price growth was +32.94%, and the average quarterly price growth was +6.79%.

Reported Earning Dates

EYPT is expected to report earnings on Jul 30, 2025.

LYRA is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($663M) has a higher market cap than LYRA($12.1M). EYPT YTD gains are higher at: 29.396 vs. LYRA (-11.725). LYRA has higher annual earnings (EBITDA): -44.7M vs. EYPT (-144.55M). EYPT has more cash in the bank: 318M vs. LYRA (31.7M). EYPT has less debt than LYRA: EYPT (24.1M) vs LYRA (33.4M). EYPT has higher revenues than LYRA: EYPT (56M) vs LYRA (1.19M).
EYPTLYRAEYPT / LYRA
Capitalization663M12.1M5,479%
EBITDA-144.55M-44.7M323%
Gain YTD29.396-11.725-251%
P/E RatioN/AN/A-
Revenue56M1.19M4,726%
Total Cash318M31.7M1,003%
Total Debt24.1M33.4M72%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
17
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EYPTLYRA
RSI
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
77%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 18 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFQCX6.870.05
+0.73%
Janus Henderson Global Equity Income C
MNRMX39.420.27
+0.69%
Manor
TLAFX11.630.06
+0.52%
Transamerica Large Core ESG R4
ARYCX24.960.12
+0.48%
American Century Real Estate C
EKBDX14.510.01
+0.07%
Allspring Diversified Cap Bldr Adm

LYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYRA has been closely correlated with ROQAF. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if LYRA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYRA
1D Price
Change %
LYRA100%
-31.91%
ROQAF - LYRA
85%
Closely correlated
N/A
EYPT - LYRA
58%
Loosely correlated
-7.04%
VERA - LYRA
54%
Loosely correlated
-2.75%
KYMR - LYRA
50%
Loosely correlated
-3.48%
BPMC - LYRA
42%
Loosely correlated
-0.03%
More